Recombinant anti-human-Amyloid Beta Antibody (Lecanemab Biosimilar)
Produktgrößen
50 µg
£550,00
12-9407-50UG
Über dieses Produkt
- SKU:
- 12-9407
- Zusätzliche Namen:
- Amyloid beta; Lecanemab
- Klonalität:
- Monoclonal
- Weitere Details:
- Target: Amyloid Beta Generic name: Lecanemab Product Origin: Recombinant in Human cells People with Alzheimer’s disease have a protein called amyloid that continuously builds up in the brain. It starts with small forms of amyloid protein. These may clump together into larger forms; which can damage the brain cells. As they continue to build up; they can form harmful amyloid brain plaques. Lecanemab is humanized monoclonal antibodies targeting cerebral amyloid-beta (A-²) plaques. References: 1. Panza F; Lozupone M; Logroscino G; Imbimbo BP. A critical appraisal of amyloid--²-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2019;15(2):73-88..
- Format:
- Purified
- Isotyp:
- human IgG1
- Aufreinigung:
- Purified from cell culture supernatant by affinity chromatography
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- Store at -20[o]C. Avoid repeated freeze and thaw cycles.
- Hersteller:
- Abeomics
- Typ:
- Antibodies:Monoclonal Antibody
- Datenblatt des Herstellers:download_pdf.php